期刊文献+

PPARα/PGC-1α信号通路对阿霉素损伤H9c2心肌细胞能量代谢的调节 被引量:5

The energy metabolism regulation of PPARα/PGC-1α signal pathway in H9c2 cardiomyocytes treated with doxorubcin
原文传递
导出
摘要 目的:探讨过氧化物酶体增生物激活受体α(PPARα)/过氧化物酶体增殖物激活受体γ辅助激活因子1α(PGC-1α)信号通路对阿霉素损伤后H9c2心肌细胞能量代谢的调节。方法:将传代后生长良好的H9c2心肌细胞随机分为4组:空白对照组(C组)、阿霉素损伤组(DI组)、PPARα预激动组(PPA组)和PPARα预抑制组(PPI组),药物预处理后予以阿霉素建立心肌细胞损伤模型。细胞继续培养24h后,荧光定量RT-PCR方法检测PPARα、PGC-1α和P300基因表达变化,运用Western blotting方法测定PPARα、PGC-1α及P300蛋白表达情况,高效液相色谱法(HPLC)测细胞线粒体内的腺苷酸含量。结果:与对照组相比,阿霉素损伤组、PPARα预抑制组中PPARα、PGC-1α及P300的表达均下降(P<0.01),高能磷酸盐的含量均显著降低(P<0.01)。与阿霉素损伤组、PPARα预抑制组相比,PPARα预激活能够提高PPARα、PGC-1α及P300的表达(P<0.01),增加高能磷酸盐的含量(P<0.01)。结论:阿霉素能够通过减少PPARα/PGC-1α轴的表达降低H9c2心肌细胞内磷酸腺苷含量,影响H9c2心肌细胞的能量代谢。而PPARα/PGC-1α轴的预激活能够增加阿霉素损伤H9c2心肌细胞磷酸腺苷的含量,改善H9c2心肌细胞能量代谢。 Objective:To investigate the energy metabolism regulation of Peroxisome proliferator activated receptorα(PPARα)and Peroxisome proliferator activate coactivator(PGC-1α)pathway in H9c2 cardiomyocytes treated with DOX(Doxorubcin).Method:H9c2 rat cardiomyocytes were randomly divided into four groups:Control group(Group C),DOX group(Group DI),PPARαpre-agonist group(PPA group),PPARαpre-inhibit group(PPI group).PPARα,PGC-1α and P300 protein levels and mRNA expression were analyzed by Western Blotting and Real-time PCR.The size of adenine acid pool were measured by High Performance Liquid Chromatography(HPLC).Result:Compared with the Control group,the expression of PPARα,PGC-1α and P300,as well as high energy phosphate content were decreased in DI group and PPI group(P〈0.01)..Compared with DI group and PPI group,pre-activation of PPARαincreased the PPARα,PGC-1αand P300 mRNA and protein expression(P〈0.01),and the content of high energy phosphate also increased(P〈0.01).Conclusion:DOX can reduce the energy metabolism of H9c2 cardiomyocytes through impress the PPARα/PGC-1α signal pathway.Pre-activation of PPARα/PGC-1α signal pathway can increase the high energy phosphate in H9c2 cardiomycytes,and protect the energy metabolism from the DOX damage.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2016年第4期388-391,共4页 Journal of Clinical Cardiology
基金 国家自然科学基金资助项目(No:81260053)
关键词 PPARΑ PGC-1Α P300 阿霉素 H9C2心肌细胞 能量代谢 PPARα PGC-1α P300 Doxorubcin H9C2rat cardiomyocytes Energy metatbolism
  • 相关文献

参考文献16

  • 1CARVALHO F S,BURGEIRO A.Doxorubicin-induced cardiotoxicity:from bioenergetic failure and cell death to cardiomyopathy[J].Med Res Rev,2014,34:106-135.
  • 2ROWE G C.PGC-1coactivators in cardiac development and disease[J].Med Res Rev,2010,107:825-838.
  • 3BOTKER H E,KIMOSE H H,HELLIGSO P,et al.Analytical evaluation of high energy phosphate determination by high performance iquid chromatography in myocardial tissue[J].J Mol Cell Cardiol,1994,26:41-45.
  • 4BOTKER H E.Oxidative damage precedes nitrative damage in adriamycirrinduccd cardiac mitochondrial injury[J].Toxicol Pathol,2004,32:536-547.
  • 5DUAN D D.A leakage leads to failure:roles of sarcoplasmic reticulum Ca2+leak via RyR2in heart failure progression[J].Hypertension,2010,55:849-851.
  • 6LEBRECHT D,SETZER B,KETELSEN U P,et al.Time-dependent and tissuesp-ecific accumulation of mtDNA and respiratory chain defects in chronic doxorubicin cardiomyopathy[J].Circulation,2003,108:2423-2429.
  • 7TAKEMURA G,FUJIWARA H.Doxorubicin-induced cardiomyopathy from the cardiotoxic mechanisms to management[J].Prog Cardiovasc Dis,2007,49:330-352.
  • 8ASCENSAO A,MAGALHAES J,SOARES J M,et al.Moderate endurance training prevents doxorubicin-induced in vivo mitochondriopathy and reduces the development of cardiac apoptosis[J].Am J Physiol Heart Circ Physiol,2005,289:H722-H731.
  • 9MINOTTI G,MENNA P,SALVATORELLI E,et al.Anthracyclines:Molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity[J].Pharmacol Rev,2004,56:185-229.
  • 10PEREIRA G C,PEREIRA S P,PEREIRA C V,et al.Mitochondrionopathy phenotype in doxorubicin treated wistar rats depends on treatment protocol and is cardiac-specific[J].PLoS One,2012,7:e38867.

同被引文献44

引证文献5

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部